Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Baxter
AstraZeneca
Mallinckrodt
Colorcon

Last Updated: June 27, 2022

CLINICAL TRIALS PROFILE FOR ZTLIDO


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Ztlido

Trial ID Title Status Sponsor Phase Start Date Summary
NCT04149938 ↗ Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects Completed Scilex Pharmaceuticals, Inc. Phase 1 2016-09-28 The purpose of this study is to characterize the comparative single-dose pharmacokinetics (bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm® (lidocaine patch 5%,reference product).
NCT04150536 ↗ Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise Completed Scilex Pharmaceuticals, Inc. Phase 1 2016-01-08 The objectives of this study are to evaluate the pharmacokinetic and adhesion performance of ZTlido (lidocaine topical system) 1.8% during physical exercise, application of heat, and under normal conditions.
NCT04312750 ↗ Adhesion of Lidocaine Topical System 1.8% Completed Scilex Pharmaceuticals, Inc. Phase 1 2015-12-01 The objective of this study is to evaluate the adhesion performance of ZTlido (lidocaine topical system) 1.8% in normal, healthy volunteers.
NCT04319926 ↗ Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects Completed Scilex Pharmaceuticals, Inc. Phase 1 2018-09-07 An open label, randomized, two-treatment, two-period, single-dose study evaluating the product adhesion in healthy, adult subjects using ZTlido 1.8% Topical System and a generic Lidocaine Patch 5%
NCT04320173 ↗ Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects Completed Scilex Pharmaceuticals, Inc. Phase 1 2017-02-14 The primary objective of this study was to evaluate the adhesion performance of ZTlido® (lidocaine topical system) 1.8% compared to adhesion performance for Lidoderm® (lidocaine patch 5%) and Versatis® (lidocaine medicated plaster 5%).
NCT04784728 ↗ Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure Completed Scilex Pharmaceuticals, Inc. Phase 1 2019-08-21 The objectives of this study are to evaluate the adhesion performance and pharmacokinetics of ZTlido (lidocaine topical system) 1.8% during swimming, showering, and under normal conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ztlido

Condition Name

Condition Name for Ztlido
Intervention Trials
Healthy 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ztlido
Intervention Trials
Tissue Adhesions 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ztlido

Trials by Country

Trials by Country for Ztlido
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ztlido
Location Trials
Minnesota 4
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ztlido

Clinical Trial Phase

Clinical Trial Phase for Ztlido
Clinical Trial Phase Trials
Phase 1 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ztlido
Clinical Trial Phase Trials
Completed 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ztlido

Sponsor Name

Sponsor Name for Ztlido
Sponsor Trials
Scilex Pharmaceuticals, Inc. 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ztlido
Sponsor Trials
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Boehringer Ingelheim
Colorcon
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.